EndoGel
Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel
April 19, 2024 03:00 ET | FUJIFILM Europe GmbH
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal...
FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows
July 03, 2023 03:00 ET | FUJIFILM Sonosite, Inc.
BOTHELL, Wash., July 03, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the...
Picture1 (1).jpg
Kymanox Acquires EU based Anteris Medical and Anteris Helvetia
February 02, 2023 13:57 ET | Kymanox Corporation
MORRISVILLE, N.C. and HOLZKIRCHEN, Germany and KÜSSNACHT A.R., Switzerland, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively...
L'engagement de fina
L'engagement de financement contribue à supprimer les obstacles qui empêchent les Canadiens atteints de diabète de type 1 d'accéder à des technologies conçues pour leur survie.
May 26, 2021 11:00 ET | Juvenile Diabetes Research Foundation
TORONTO, 26 mai 2021 (GLOBE NEWSWIRE) -- Chaque jour, pas moins de 300 000 Canadiens atteints de diabète de type 1 (DT1) devront prendre jusqu'à 300 décisions sur leurs soins. Une mauvaise décision...
JDRF Logo_CMYK.jpg
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes
May 26, 2021 11:00 ET | Juvenile Diabetes Research Foundation
TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or...